Informationen:
Fehler:
ID
12991
Beschreibung
Treatment of Mature B-cell Lymphoma/Leukaemia; ODM derived from: https://clinicaltrials.gov/show/NCT00162656
Link
https://clinicaltrials.gov/show/NCT00162656
Stichworte
Versionen (1)
- 10.01.16 10.01.16 -
Hochgeladen am
10. Januar 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility B-Cell Lymphoma NCT00162656
Eligibility B-Cell Lymphoma NCT00162656
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility B-Cell Lymphoma NCT00162656
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
B-NHL, Diffuse large cell, Burkitt, High grade, burkitt-like lymphoma, bone marrow blasts
Item
newly diagnosed b lineage non-hodgkin's lymphoma with revised european american lymphoma (real) ii 9 (diffuse large cell lymphoma), 10 (burkitt's lymphoma), or 11 (high grade b cell lymphoma, burkitt's like) or bone marrow > 5% l3 blasts.
boolean
C0079731 (UMLS CUI [1])
C0024305 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
C0456863 (UMLS CUI [4])
C0006413 (UMLS CUI [5])
C1368771 (UMLS CUI [6])
C1982687 (UMLS CUI [7])
C0024305 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
C0456863 (UMLS CUI [4])
C0006413 (UMLS CUI [5])
C1368771 (UMLS CUI [6])
C1982687 (UMLS CUI [7])
murphy disease stage
Item
pre treatment imaging studies adequate to document murphy disease stage
boolean
C0699749 (UMLS CUI [1])
randomization
Item
group b and c patients are eligible for randomization (therapy stratification by group : group a=completely resected stage i or completely resected abdominal stage ii lesions, group b= all cases not eligible for group a or group c, group c= any cns involvement and/or bone marrow involvement ³ 25% blasts)
boolean
C0034656 (UMLS CUI [1])
Follow up
Item
patients should be available for a minimum follow up of 36 months
boolean
C1522577 (UMLS CUI [1])
informed consent
Item
informed consent prior to study entry
boolean
C0021430 (UMLS CUI [1])
anaplastic large cell ki 1 positive lymphomas
Item
anaplastic large cell ki 1 positive lymphomas
boolean
C0206180 (UMLS CUI [1])
chemotherapy
Item
previous chemotherapy.
boolean
C0392920 (UMLS CUI [1])
congenital immunodeficiency
Item
congenital immunodeficiency
boolean
C0021051 (UMLS CUI [1,1])
C0853602 (UMLS CUI [1,2])
C0853602 (UMLS CUI [1,2])
organ transplantation
Item
prior organ transplantation
boolean
C0029216 (UMLS CUI [1])
malignancy
Item
previous malignancy of any type
boolean
C0006826 (UMLS CUI [1])
hiv positivity
Item
known hiv positivity
boolean
C0019699 (UMLS CUI [1])